Identification of new epigenetic targets in hepatic fibrosis

被引:0
|
作者
Barcena-Varela, Marina [1 ]
Paish, Hannah [2 ]
Alvarez, Laura [1 ]
Oyarzabal, Julen [3 ]
Prosper, Felipe [4 ]
Mazza, Giuseppe [5 ]
Rombouts, Krista
Oakley, Fiona [2 ]
Mann, Jelena [2 ]
Berasain, Carmen [1 ,6 ]
Avila, Matias A. [1 ,6 ]
Fernandez-Barrena, Maite G. [1 ,6 ]
机构
[1] Univ Navarra, CIMA, Hepatol Program, Pamplona, Spain
[2] Newcastle Univ, NFRG, Newcastle Upon Tyne, Tyne & Wear, England
[3] Univ Navarra, CIMA, Mol Therapies Program, Pamplona, Spain
[4] Univ Navarra, CIMA, Oncohematol Program, Pamplona, Spain
[5] Univ Collage London, Liver & Digest Health, London, England
[6] CIBERehd, Madrid, Spain
关键词
D O I
10.1016/S0618-8278(19)30345-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-064
引用
收藏
页码:E188 / E188
页数:1
相关论文
共 50 条
  • [1] Exploration of new therapeutic targets for viral hepatic fibrosis, alcoholic hepatic fibrosis, and non-alcoholic hepatic fibrosis
    Wang, Xiaoling
    Wang, Ying
    Li, Xuewei
    Qin, Shuo
    Xu, Jun
    Xie, Jun
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (16)
  • [2] Epigenetic targets and their inhibitors in the treatment of idiopathic pulmonary fibrosis
    Miao, Xiaohui
    Liu, Pan
    Liu, Yangyang
    Zhang, Wenying
    Li, Chunxin
    Wang, Xiujiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289
  • [3] Emerging therapeutic targets for the treatment of hepatic fibrosis
    Fagone, Paolo
    Mangano, Katia
    Pesce, Antonio
    Portale, Teresa Rosanna
    Puleo, Stefano
    Nicoletti, Ferdinando
    DRUG DISCOVERY TODAY, 2016, 21 (02) : 369 - 375
  • [4] Hepatic fibrosis: Molecular mechanisms and drug targets
    Lotersztajn, S
    Julien, B
    Teixeira-Clerc, F
    Grenard, P
    Mallat, A
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 605 - 628
  • [5] Identification of Epigenetic Targets in the Treatment of Recurrent Breast Cancer
    Mabe, Nathaniel Wesley
    FASEB JOURNAL, 2017, 31
  • [6] Epigenetic regulation of hepatic stellate cell activation and liver fibrosis
    El Taghdouini, Adil
    van Grunsven, Leo A.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (12) : 1397 - 1408
  • [7] Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
    Claveria-Cabello, Alex
    Maria Herranz, Jose
    Adan-Villaescusa, Elena
    Latasa, Maria U.
    Arechederra, Maria
    Uriarte, Iker
    Pineda, Antonio A.
    Berraondo, Pedro
    Sangro, Bruno
    Marin, Jose
    Martinez-Chantar, Maria Luz
    Ciordia, Sergio
    Corrales, Fernando
    Zucman-Rossi, Jessica
    Indersie, Emilie
    Cairo, Stefano
    Domingo-Sabat, Montserrat
    Berasain, Carmen
    Fernandez-Barrena, Maite G.
    Avila, Matias A.
    JOURNAL OF HEPATOLOGY, 2023, 78 : S537 - S538
  • [8] Epigenetic Modifications in Hepatic Stellate Cells Contribute to Liver Fibrosis
    Zhao, Qi
    Qin, Cheng-Yong
    Zhao, Ze-Hua
    Fan, Yu-Chen
    Wang, Kai
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 229 (01): : 35 - 43
  • [9] Identification and experimental validation of druggable epigenetic targets in hepatoblastoma
    Claveria-Cabello, Alex
    Herranz, Jose Maria
    Latasa, Maria Ujue
    Arechederra, Maria
    Uriarte, Iker
    Pineda-Lucena, Antonio
    Prosper, Felipe
    Berraondo, Pedro
    Alonso, Cristina
    Sangro, Bruno
    Marin, Jose Juan Garcia
    Martinez-Chantar, Maria Luz
    Ciordia, Sergio
    Corrales, Fernando Jose
    Francalanci, Paola
    Alaggio, Rita
    Zucman-Rossi, Jessica
    Indersie, Emilie
    Cairo, Stefano
    Domingo-Sabat, Montserrat
    Zanatto, Laura
    Sancho-Bru, Pau
    Armengol, Carolina
    Berasain, Carmen
    Fernandez-Barrena, Maite Garcia
    Avila, Matias Antonio
    JOURNAL OF HEPATOLOGY, 2023, 79 (04) : 989 - 1005
  • [10] Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
    Zhang, Nana
    Yao, Huimin
    Zhang, Zhixuan
    Li, Zhuoqun
    Chen, Xue
    Zhao, Yan
    Ju, Ran
    He, Jiayi
    Pan, Heli
    Liu, Xiaoli
    Lv, Yi
    FRONTIERS IN IMMUNOLOGY, 2023, 14